Clinical Trial Update: Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery [Phase 1]

View source ↗

Summary

Phase 1 exploratory study evaluating safety and ex vivo fluorescence of BLZ-100 in adults with solid tumors undergoing surgery, including breast tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BLZ-100

Snippet

Sponsor: Blaze Bioscience Inc. | Conditions: Tumors, Breast | Phase 1 | Status: COMPLETED